Risk for Premature Mortality Increased With History of Endometriosis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- Women with a history of endometriosis and uterine fibroids may have an increased risk for premature mortality, according to a study published online Nov. 20 in The BMJ.
Yi-Xin Wang, M.D., Ph.D., from Shanghai Jiao Tong University, and colleagues conducted a prospective cohort study involving 110,091 women aged 25 to 42 years in 1989 without a history of hysterectomy before endometriosis or fibroids diagnosis, cardiovascular diseases, or cancer to assess the effect of endometriosis and uterine fibroids on the long-term risk for premature mortality (<70 years).
During 2,994,354 person-years of follow-up, 4,356 premature deaths were recorded, including 1,459 from cancer, 304 from cardiovascular diseases, and 90 from respiratory diseases. The researchers found that for women with and without laparoscopically confirmed endometriosis, the crude incidence of all-cause premature mortality was 2.01 and 1.40 per 1,000 person-years, respectively. Laparoscopically confirmed endometriosis was associated with a hazard ratio of 1.19 for premature death in age-adjusted models; after adjustment for potential confounders, including behavioral factors, these models were strengthened (hazard ratio, 1.31). The association was mainly driven by senility and ill-defined disease, nonmalignant respiratory diseases, diseases of the nervous system and sense organs, and malignant neoplasms of gynecological organs (hazard ratios, 1.80, 1.95, 2.50, and 2.76, respectively). There was no association seen for ultrasound or hysterectomy-confirmed uterine fibroids with all-cause premature mortality, but associations were seen with an increased risk for mortality from malignant neoplasm of gynecological organs (hazard ratio, 2.32).
"These findings highlight the importance for primary care providers to consider both conditions in their assessment of women's health," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-22 12:00
Read more
- Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation from FDA for Treatment of Triple Negative Breast Cancer (TNBC)
- As Daily Steps Rise, Depression Levels Fall
- Cognitive Behavioral Therapy Aids Patients With Long COVID
- Prior Authorization Leads to Radiation Oncology Treatment Delays, Patient Harm
- Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura
- Opioid Abuse Can Change the Brain
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions